Nomad Power Solutions, Inc., formerly known as Lixte Biotechnology Holdings, Inc., reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2026. The company recorded a net loss of $4.33 million for the first half of 2026, compared to a loss of $1.49 million during the same period in 2025. The increase in losses was primarily attributed to a substantial rise in general and administrative expenses, which surged to $3.94 million from $1.33 million year-over-year. The company has not yet generated any revenue since its inception, and its cash position at the end of June 2026 stood at $12.67 million, a notable increase from $5.11 million at the end of 2025.

The company's operational focus has shifted significantly, as it announced a strategic transformation to expand into AI energy infrastructure equipment and services. This change was marked by a definitive merger agreement with NOMAD Transportable Power Systems, Inc., which was finalized on July 1, 2026. Following the merger, the company rebranded itself as Nomad Power Solutions, Inc. and began trading on the Nasdaq under the ticker symbol "NMAD." The merger is expected to enhance the company's capabilities in deployable, utility-grade battery energy storage systems.

In terms of operational metrics, the company reported an increase in its employee headcount, reflecting its expansion efforts. As of June 30, 2026, the total number of common shares outstanding rose to 15.42 million from 8.79 million at the end of 2025, following various equity transactions, including a registered direct offering that generated approximately $16.57 million in gross proceeds. The company also advanced $6.5 million to NOMAD under a secured promissory note, which was part of the merger agreement.

Despite these developments, the company faces significant challenges, including the need for additional capital to fund its ongoing clinical trials and operational expenses. Management has expressed substantial doubt regarding the company's ability to continue as a going concern for at least the next 12 months, given its recurring losses and reliance on external financing. The company is actively exploring various financing alternatives, including equity and debt options, to support its operations and development programs.

Looking ahead, Nomad Power Solutions, Inc. aims to leverage its merger with NOMAD to diversify its business model and enhance its market position in the energy sector. However, the company acknowledges the inherent risks associated with its clinical development programs and the uncertainty surrounding future revenue generation. The management's focus will remain on securing the necessary funding and navigating the complexities of its expanded operational landscape.

About NOMAD POWER SOLUTIONS, INC.

Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies, primarily focusing on inhibitors of protein phosphatase 2A, such as LB-100. Its pipeline aims to enhance existing treatments like chemotherapy and immunotherapy across various cancers. The company advances its products through clinical trials, seeking regulatory approval and strategic partnerships, with a strong emphasis on innovative mechanisms and intellectual property protection.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov